Phase I trial of R 118 in healthy volunteers

Trial Profile

Phase I trial of R 118 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 13 Aug 2014

At a glance

  • Drugs R 118 (Primary)
  • Indications Intermittent claudication
  • Focus Adverse reactions
  • Sponsors Rigel Pharmaceuticals
  • Most Recent Events

    • 13 Aug 2014 Results published in Rigel Pharmaceuticals media release.
    • 13 Aug 2014 Rigel Pharmaceuticals has discontinued the R 118 programme due to the side-effect profile in phase I trials, according to a media release.
    • 13 Aug 2014 Status changed from recruiting to discontinued, according to a Rigel Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top